Summary
The role of fibrinogen in the pathophysiology of pulmonary embolism is not clearly
understood. A study was therefore performed in order to determine the effect of defibrinogenation
on the sequelae of experimental pulmonary embolization in the canine model. Total
defibrinogenation was achieved by treating 15 dogs with Defibrase over a period of
three days, and these were studied and compared with 15 control animals. The embolus
was produced by injection of a homologous clot into the superior vena cava. A 27 per
cent mortality rate was observed after embolism in the control group, but there were
no deaths in the Defibrase-treated animals. Hemodynamic and pulmonary gas exchange
disturbances occuring in the control group were more severe than those in the treated
group and were associated with marked fibrinogen consumption. It is suggested, therefore,
that defibrinogenation reduces the mortality and severity of the pathophysiological
changes associated with pulmonary embolization probably by inhibition of pulmonary
intravascular coagulation and by changing the rheological properties of the blood.